{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:00:11Z","timestamp":1786993211295,"version":"build-2736575974"},"reference-count":131,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014832","name":"Reykjavik University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100028250","name":"Studio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpet.2026.104900","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:28:15Z","timestamp":1777073295000},"page":"104900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reinventing amlodipine"],"prefix":"10.1016","volume":"393","author":[{"given":"Bartosz","family":"Grzymala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar \u00de\u00f6ll","family":"Halld\u00f3rsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-7333","authenticated-orcid":false,"given":"Haraldur","family":"\u00deorsteinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist\u00edn","family":"\u00deorfinnsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0684-8213","authenticated-orcid":false,"given":"Hildur S\u00f3ley","family":"Sveinsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7172-5231","authenticated-orcid":false,"given":"Matthew O.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-0748","authenticated-orcid":false,"given":"Sebastien","family":"Foulquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5931-8422","authenticated-orcid":false,"given":"Karl \u00c6gir","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9-10","key":"10.1016\/j.jpet.2026.104900_bib1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1017\/S1355617717000807","article-title":"Attention-deficit\/hyperactivity disorder: a historical neuropsychological perspective","volume":"23","author":"Mahone","year":"2017","journal-title":"J Int Neuropsychol Soc"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib2","first-page":"467","article-title":"ADHD diagnostic trends: increased recognition or overdiagnosis?","volume":"119","author":"Abdelnour","year":"2022","journal-title":"Mo Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12888-017-1463-3","article-title":"Adult ADHD and comorbid disorders: clinical implications of a dimensional approach","volume":"17","author":"Katzman","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/appi.ajp.2021.21010032","article-title":"Variable patterns of remission from ADHD in the multimodal treatment study of ADHD","volume":"179","author":"Sibley","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.jpet.2026.104900_bib5","first-page":"192","article-title":"A review of pharmacological management of attention-deficit\/hyperactivity disorder","volume":"21","author":"Briars","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jpet.2026.104900_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113861","article-title":"Retrospective analysis of adverse events associated with non-stimulant ADHD medications reported to the United States food and drug administration","volume":"300","author":"Pang","year":"2021","journal-title":"Psychiatry Res"},{"issue":"11","key":"10.1016\/j.jpet.2026.104900_bib7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMra1917069","article-title":"Pharmacologic treatment of attention deficit-hyperactivity disorder","volume":"383","author":"Cortese","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ J Bioorg Chem"},{"issue":"3","key":"10.1016\/j.jpet.2026.104900_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13311-017-0532-0","article-title":"From gene to behavior: L-type calcium channel mechanisms underlying neuropsychiatric symptoms","volume":"14","author":"Kabir","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.jpet.2026.104900_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220649120","article-title":"L-type Ca2+ channels mediate regulation of glutamate release by subthreshold potential changes","volume":"120","author":"Lee","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jpet.2026.104900_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109336","article-title":"L-type calcium channel regulation of dopamine activity in the ventral tegmental area to nucleus accumbens pathway: implications for substance use, mood disorders and co-morbidities","volume":"224","author":"Nunes","year":"2023","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.jpet.2026.104900_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamapsychiatry.2024.1112","article-title":"Key roles of CACNA1C\/Cav1.2 and CALB1\/calbindin in prefrontal neurons altered in cognitive disorders","volume":"81","author":"Datta","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1523\/JNEUROSCI.3327-04.2005","article-title":"G-protein-coupled receptor modulation of striatal CaV1.3 L-Type Ca2+ channels is dependent on a shank-binding domain","volume":"25","author":"Olson","year":"2005","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2006.07.019","article-title":"Expression pattern of voltage-dependent calcium channel subunits in hippocampal inhibitory neurons in mice","volume":"143","author":"Vinet","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpet.2026.104900_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/NSA.S232517","article-title":"Loading amlodipine on diamond nanoparticles: a novel drug delivery system","volume":"12","author":"Alawdi","year":"2019","journal-title":"Nanotechnol Sci Appl"},{"issue":"9","key":"10.1016\/j.jpet.2026.104900_bib16","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1038\/s41380-022-01615-6","article-title":"Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders","volume":"27","author":"Colbourne","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.jpet.2026.104900_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098961","article-title":"Antihypertensive agents and risk of Parkinson\u2019s disease: a nationwide cohort study","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jpet.2026.104900_bib18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41386-022-01505-z","article-title":"Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD","volume":"48","author":"Sveinsd\u00f3ttir","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.jpet.2026.104900_bib19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41386-025-02062-x","article-title":"Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records","volume":"50","author":"\u00feorsteinsson","year":"2025","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1152\/jn.00757.2013","article-title":"Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area","volume":"112","author":"Liu","year":"2014","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jpet.2026.104900_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2014.03.021","article-title":"Psychostimulants, antidepressants and neurokinin-1 receptor antagonists (\u2018motor disinhibitors\u2019) have overlapping, but distinct, effects on monoamine transmission: the involvement of L-type Ca2+ channels and implications for the treatment of ADHD","volume":"87","author":"Stanford","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2023.2176984","article-title":"L-type calcium channels and neuropsychiatric diseases: Insights into genetic risk variant-associated genomic regulation and impact on brain development","volume":"17","author":"Baker","year":"2023","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.jpet.2026.104900_bib23","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16104.1","article-title":"Voltage-gated calcium channel \u03b1 2\u03b4 subunits: an assessment of proposed novel roles","volume":"7","author":"Dolphin","year":"2018","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41583-020-0278-2","article-title":"Presynaptic calcium channels: specialized control of synaptic neurotransmitter release","volume":"21","author":"Dolphin","year":"2020","journal-title":"Nat Rev Neurosci"},{"issue":"D1","key":"10.1016\/j.jpet.2026.104900_bib25","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002130000518","article-title":"Repeated stimulation of L-type calcium channels in the rat ventral tegmental area mimics the initiation of behavioral sensitization to cocaine","volume":"152","author":"Licata","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jpet.2026.104900_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/mp.2015.84","article-title":"L-type Ca2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory","volume":"21","author":"Degoulet","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"12","key":"10.1016\/j.jpet.2026.104900_bib28","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/s41386-018-0080-2","article-title":"The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway","volume":"43","author":"Addy","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jpet.2026.104900_bib29","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/j.celrep.2016.11.076","article-title":"Calcium release from stores inhibits GIRK","volume":"17","author":"Kramer","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpet.2026.104900_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.conb.2018.08.013","article-title":"Synaptic and intrinsic plasticity in the ventral tegmental area after chronic cocaine","volume":"54","author":"Francis","year":"2019","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.jpet.2026.104900_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mcn.2015.08.012","article-title":"A concerted action of L- and T-type Ca2 + channels regulates locus coeruleus pacemaking","volume":"68","author":"Matschke","year":"2015","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2130","article-title":"Working memory in schizophrenia: the role of the locus coeruleus and its relation to functional brain networks","volume":"11","author":"Suttkus","year":"2021","journal-title":"Brain Behav"},{"issue":"11","key":"10.1016\/j.jpet.2026.104900_bib33","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1111\/ejn.14553","article-title":"Axonal projection-specific differences in somatodendritic \u03b12 autoreceptor function in locus coeruleus neurons","volume":"50","author":"Wagner-Altendorf","year":"2019","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jpet.2026.104900_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ynstr.2014.10.002","article-title":"The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder","volume":"1","author":"Arnsten","year":"2015","journal-title":"Neurobiol Stress"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-3223(98)00296-0","article-title":"Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function","volume":"45","author":"Arnsten","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpet.2026.104900_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102670","article-title":"A functional magnetic resonance imaging investigation of prefrontal cortex deep transcranial magnetic stimulation efficacy in adults with attention deficit\/hyperactive disorder: a double blind, randomized clinical trial","volume":"30","author":"Bleich-Cohen","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"12","key":"10.1016\/j.jpet.2026.104900_bib37","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1523\/JNEUROSCI.22-12-05239.2002","article-title":"NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala","volume":"22","author":"Bauer","year":"2002","journal-title":"J Neurosci"},{"issue":"24","key":"10.1016\/j.jpet.2026.104900_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms222413551","article-title":"Age-dependent contributions of NMDA receptors and L-type calcium channels to long-term depression in the piriform cortex","volume":"22","author":"Rajani","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.104900_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S1807-59322011001300002","article-title":"Long-term potentiation and long-term depression: a clinical perspective","volume":"66","author":"Bliss","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jpet.2026.104900_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1093099","article-title":"Insights into the role of intracellular calcium signaling in the neurobiology of neurodevelopmental disorders","volume":"17","author":"Klocke","year":"2023","journal-title":"Front Neurosci"},{"issue":"9","key":"10.1016\/j.jpet.2026.104900_bib41","first-page":"1241","article-title":"Attention deficit-hyperactivity disorder (adhd): from abnormal behavior to impairment in synaptic plasticity","volume":"12","author":"Ugarte","year":"2023","journal-title":"Biology (Basel)"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.18203\/2319-2003.ijbcp20201747","article-title":"A comparative study between cilnidipine and amlodipine on learning and memory in albino mice","volume":"9","author":"Veena","year":"2020","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(00)00368-X","article-title":"Chronic administration of the Ca2+ channel blocker amlodipine facilitates learning and memory in mice","volume":"399","author":"Quartermain","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104900_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0163-1047(93)90390-4","article-title":"Effect of the calcium channel blocker amlodipine on memory in mice","volume":"60","author":"Quartermain","year":"1993","journal-title":"Behav Neural Biol"},{"key":"10.1016\/j.jpet.2026.104900_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mcn.2014.12.004","article-title":"The L-type voltage-gated calcium channel modulates microglial pro-inflammatory activity","volume":"64","author":"Espinosa-Parrilla","year":"2015","journal-title":"Mol Cell Neurosci"},{"issue":"21","key":"10.1016\/j.jpet.2026.104900_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113606","article-title":"L-Type Ca2+ channel inhibition rescues the LPS-induced neuroinflammatory response and impairments in spatial memory and dendritic spine formation","volume":"23","author":"Kim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104900_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pbb.2019.05.005","article-title":"Neuroinflammation as a risk factor for attention deficit hyperactivity disorder","volume":"182","author":"Dunn","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"issue":"20","key":"10.1016\/j.jpet.2026.104900_bib48","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.191352298","article-title":"Calcium regulation of neuronal gene expression","volume":"98","author":"West","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1471-4159.2001.00645.x","article-title":"CREB\/CBP and SRE-interacting transcriptional regulators are fast on\u2013off switches: duration of calcium transients specifies the magnitude of transcriptional responses","volume":"79","author":"Chawla","year":"2001","journal-title":"J Neurochem"},{"issue":"17","key":"10.1016\/j.jpet.2026.104900_bib50","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1046\/j.1432-1327.2000.01565.x","article-title":"Transcription-dependent neuronal plasticity","volume":"267","author":"Bading","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jpet.2026.104900_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.arr.2018.01.001","article-title":"Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: implications in age-related synaptic dysfunction and cognitive decline","volume":"42","author":"Navakkode","year":"2018","journal-title":"Ageing Res Rev"},{"issue":"23","key":"10.1016\/j.jpet.2026.104900_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313133","article-title":"Calcium ions in the physiology and pathology of the central nervous system","volume":"25","author":"Pikor","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jpet.2026.104900_bib53","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s44159-024-00350-9","article-title":"Executive function deficits in attention-deficit\/hyperactivity disorder and autism spectrum disorder","volume":"3","author":"Kofler","year":"2024","journal-title":"Nat Rev Psychol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib54","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41380-025-03429-8","article-title":"Aberrant calcium signaling and neuronal activity in the L271H CACNA1D (Cav1.3) iPSC model of neurodevelopmental disease","volume":"31","author":"Tisch","year":"2026","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/srep13688","article-title":"Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice","volume":"5","author":"Poetschke","year":"2015","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jpet.2026.104900_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137326","article-title":"Attenuated tonic and enhanced phasic release of dopamine in attention deficit hyperactivity disorder","volume":"10","author":"Badgaiyan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2026.104900_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107583","article-title":"Dopamine D2 autoreceptor interactome: targeting the receptor complex as a strategy for treatment of substance use disorder","volume":"213","author":"Chen","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jpet.2026.104900_bib58","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/brain\/awu131","article-title":"Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons","volume":"137","author":"Dragicevic","year":"2014","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jpet.2026.104900_bib59","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nn.3717","article-title":"Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase","volume":"17","author":"Sanchez-Padilla","year":"2014","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib60","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1152\/ajpcell.00346.2002","article-title":"Multiple targets of chemosensitive signaling in locus coeruleus neurons: role of K+ and Ca2+channels","volume":"284","author":"Filosa","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","article-title":"\u03b12A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex","volume":"129","author":"Wang","year":"2007","journal-title":"Cell"},{"issue":"Pt B","key":"10.1016\/j.jpet.2026.104900_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainres.2015.11.024","article-title":"Differential cognitive actions of norepinephrine \u03b12 and \u03b11 receptor signaling in the prefrontal cortex","volume":"1641","author":"Berridge","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.jpet.2026.104900_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychires.2021.02.005","article-title":"Association of working memory and elevated overnight urinary norepinephrine in patients with schizophrenia","volume":"137","author":"Savransky","year":"2021","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jpet.2026.104900_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6031478","article-title":"Noradrenergic modulation of cognition in health and disease","volume":"2017","author":"Borodovitsyna","year":"2017","journal-title":"Neural Plast"},{"issue":"8","key":"10.1016\/j.jpet.2026.104900_bib65","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0269881113480988","article-title":"Noradrenergic modulation of cognition: therapeutic implications","volume":"27","author":"Chamberlain","year":"2013","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/neuroglia5040027","article-title":"The alteration of microglial calcium homeostasis in central nervous system disorders: a comprehensive review","volume":"5","author":"Hasan","year":"2024","journal-title":"Neuroglia"},{"key":"10.1016\/j.jpet.2026.104900_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400533","article-title":"The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions","volume":"15","author":"Kerkis","year":"2024","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104900_bib68","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib69","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"36","key":"10.1016\/j.jpet.2026.104900_bib70","doi-asserted-by":"crossref","first-page":"E5078","DOI":"10.1073\/pnas.1514486112","article-title":"Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1\u03b2 in the aged hippocampus","volume":"112","author":"Prieto","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.jpet.2026.104900_bib71","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/antiox9111039","article-title":"Role of oxidative stress and neuroinflammation in attention-deficit\/hyperactivity disorder","volume":"9","author":"Corona","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jpet.2026.104900_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1492126","article-title":"The dopamine hypothesis for ADHD: an evaluation of evidence accumulated from human studies and animal models","volume":"15","author":"MacDonald","year":"2024","journal-title":"Front Psychiatry"},{"issue":"8","key":"10.1016\/j.jpet.2026.104900_bib73","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00406-022-01397-6","article-title":"Emerging findings of glutamate-glutamine imbalance in the medial prefrontal cortex in attention deficit\/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies","volume":"272","author":"Vidor","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"21","key":"10.1016\/j.jpet.2026.104900_bib74","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0024-3205(97)00881-3","article-title":"Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists","volume":"61","author":"Uchida","year":"1997","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.jpet.2026.104900_bib75","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.3390\/biomedicines10102447","article-title":"Imaging technologies for cerebral pharmacokinetic studies: progress and perspectives","volume":"10","author":"Ban","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.jpet.2026.104900_bib76","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s11095-022-03277-z","article-title":"PET imaging in preclinical anti-A\u03b2 drug development","volume":"39","author":"Syv\u00e4nen","year":"2022","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib77","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejps.2005.03.011","article-title":"Can protonated \u03b2-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC)","volume":"25","author":"Barbato","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"23","key":"10.1016\/j.jpet.2026.104900_bib78","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/j.bmc.2004.09.004","article-title":"Ionization, lipophilicity, and molecular modeling to investigate permeability and other biological properties of amlodipine","volume":"12","author":"Caron","year":"2004","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"10.1016\/j.jpet.2026.104900_bib79","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/0002-9149(94)90268-2","article-title":"Unique pharmacologic properties of amlodipine","volume":"73","author":"Burges","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jpet.2026.104900_bib80","series-title":"Amlodipine","author":"Bulsara","year":"2025"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib81","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/09727531241246671","article-title":"Amlodipine attenuates carrageenan-induced oxidative stress targeting transsynaptic neuronal damage by promoting survival of retinal ganglion cells in adult zebrafish (Danio rerio)","volume":"33","author":"Nanda","year":"2024","journal-title":"Ann Neurosci"},{"issue":"778","key":"10.1016\/j.jpet.2026.104900_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn6763","article-title":"Modeling craniopharyngioma for drug screening reveals a neuronal mechanism for tumor growth","volume":"16","author":"Li","year":"2024","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.jpet.2026.104900_bib83","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/HJH.0000000000003445","article-title":"Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice","volume":"41","author":"Kerkhofs","year":"2023","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib84","first-page":"4","article-title":"Effects of L-type voltage-gated calcium channel (LTCC) inhibition on hippocampal neuronal death after pilocarpine-induced seizure","volume":"13","author":"Lee","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"10.1016\/j.jpet.2026.104900_bib85","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/mp.2009.49","article-title":"The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia","volume":"15","author":"Green","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1016\/j.jpet.2026.104900_bib86","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108768119","article-title":"Disrupted Cacna1c gene expression perturbs spontaneous Ca2+ activity causing abnormal brain development and increased anxiety","volume":"119","author":"Smedler","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.jpet.2026.104900_bib87","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00004872-199303001-00002","article-title":"Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses","volume":"11","author":"van Zwieten","year":"1993","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.jpet.2026.104900_bib88","first-page":"12","article-title":"1,4-Dihydropyridines: the multiple personalities of a blockbuster drug family","volume":"4","author":"Cataldi","year":"2012","journal-title":"Transl Med UniSa"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib89","first-page":"67","article-title":"New generations of dihydropyridines for treatment of hypertension","volume":"14","author":"Wang","year":"2017","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib90","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib91","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0306-3623(94)00196-T","article-title":"Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system","volume":"26","author":"Gaggi","year":"1995","journal-title":"Gen Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104900_bib92","first-page":"CD000147","article-title":"Nimodipine for primary degenerative, mixed and vascular dementia","author":"L\u00f3pez-Arrieta","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib93","doi-asserted-by":"crossref","first-page":"113","DOI":"10.36011\/cpp.2023.5.e16","article-title":"Calcium channel blockers for hypertension: old, but still useful","volume":"5","author":"Lee","year":"2023","journal-title":"Cardiovasc Prev Pharmacother"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103403","article-title":"Metabolomic and lipidomic profiling reveals convergent pathways in attention deficit hyperactivity disorder therapeutics: Insights from established and emerging treatments","volume":"392","author":"Grzymala","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib95","doi-asserted-by":"crossref","first-page":"L91","DOI":"10.1152\/ajplung.00508.2005","article-title":"Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4","volume":"291","author":"Qiao","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.05.029","article-title":"Metabolism and atherogenic disease association of lysophosphatidylcholine","volume":"208","author":"Schmitz","year":"2010","journal-title":"Atherosclerosis"},{"issue":"6 Suppl 1","key":"10.1016\/j.jpet.2026.104900_bib97","doi-asserted-by":"crossref","first-page":"1539S","DOI":"10.1093\/jn\/137.6.1539S","article-title":"Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain","volume":"137","author":"Fernstrom","year":"2007","journal-title":"J Nutr"},{"issue":"7","key":"10.1016\/j.jpet.2026.104900_bib98","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpet.2026.104900_bib99","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","article-title":"Plasticity of glutamate synaptic mechanisms","author":"Nadler","year":"2012"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/cge.13421","article-title":"Linking genetics to epigenetics: the role of folate and folate-related pathways in neurodevelopmental disorders","volume":"95","author":"Lintas","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.jpet.2026.104900_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101223","article-title":"Taurine and its analogs in neurological disorders: focus on therapeutic potential and molecular mechanisms","volume":"24","author":"Jakaria Md","year":"2019","journal-title":"Redox Biol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104900_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181122","article-title":"Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib103","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.120.15605","article-title":"Antihypertensive drugs and risk of depression: a nationwide population-based study","volume":"76","author":"Kessing","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jpet.2026.104900_bib104","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10641963.2016.1174249","article-title":"Amlodipine treatment of hypertension associates with a decreased dementia risk","volume":"38","author":"Feldman","year":"2016","journal-title":"Clin Exp Hypertens"},{"issue":"Suppl 3","key":"10.1016\/j.jpet.2026.104900_bib105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1124\/jpet.122.552170","article-title":"Amlodipine use in mild cognitive impairment reduces the risk of incident dementia in National Alzheimer\u2019s Coordinating Center participants aged \u226555 years from 2014-2019","volume":"385","author":"Sandoval","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.104900_bib106","first-page":"187","article-title":"Chiral molecules in hypertension: focus on S-amlodipine","volume":"52","author":"Adik-Pathak","year":"2004","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jpet.2026.104900_bib107","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8681792","article-title":"S-amlodipine: an isomer with difference\u2014time to shift from racemic amlodipine","volume":"2018","author":"Dalal","year":"2018","journal-title":"Int J Hypertens"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib108","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00005344-200202000-00007","article-title":"Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine","volume":"39","author":"Zhang","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib109","doi-asserted-by":"crossref","first-page":"73","DOI":"10.20452\/pamw.15213","article-title":"Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: an interesting finding that deserves further studies","volume":"130","author":"Firinu","year":"2020","journal-title":"Pol Arch Intern Med"},{"issue":"10","key":"10.1016\/j.jpet.2026.104900_bib110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib111","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1089\/ars.2011.3923","article-title":"Oxidative stress and blood\u2013brain barrier dysfunction under particular consideration of matrix metalloproteinases","volume":"15","author":"Lehner","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"10.1016\/j.jpet.2026.104900_bib112","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20140654","article-title":"NOS1-derived nitric oxide promotes NF-\u03baB transcriptional activity through inhibition of suppressor of cytokine signaling-1","volume":"212","author":"Baig","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jpet.2026.104900_bib113","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fncel.2015.00322","article-title":"Implications of glial nitric oxide in neurodegenerative diseases","volume":"9","author":"Yuste","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.jpet.2026.104900_bib114","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuint.2003.11.004","article-title":"Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors","volume":"45","author":"Kiss","year":"2004","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(94)91818-X","article-title":"Nitric oxide inhibits [3H]dopamine uptake","volume":"641","author":"Pogun","year":"1994","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib116","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.bjp.0703416","article-title":"Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation","volume":"130","author":"Kaye","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104900_bib117","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjp.0703349","article-title":"Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo","volume":"130","author":"Wegener","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"9481","key":"10.1016\/j.jpet.2026.104900_bib118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","article-title":"Attention-deficit hyperactivity disorder","volume":"366","author":"Biederman","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jpet.2026.104900_bib119","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.biopsych.2011.02.036","article-title":"The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder","volume":"69","author":"Del Campo","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2026.104900_bib120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12872-016-0350-z","article-title":"Leg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial","volume":"16","author":"Galappatthy","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"10.1016\/j.jpet.2026.104900_bib121","first-page":"87","article-title":"Safety and efficacy of S(-) amlodipine","volume":"2","year":"2003","journal-title":"JAMA India"},{"issue":"9","key":"10.1016\/j.jpet.2026.104900_bib122","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jch.14709","article-title":"Amlodipine in the current management of hypertension","volume":"25","author":"Wang","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"33","key":"10.1016\/j.jpet.2026.104900_bib123","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jpet.2026.104900_bib124","article-title":"Addressing diagnosis and treatment gaps in adults with attention-deficit\/hyperactivity disorder","volume":"19","author":"Jain","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"issue":"6","key":"10.1016\/j.jpet.2026.104900_bib125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/10641963.2017.1281947","article-title":"Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects","volume":"39","author":"Khodadoustan","year":"2017","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"10.1016\/j.jpet.2026.104900_bib126","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00005344-200308000-00020","article-title":"Amlodipine improves vascular function in patients with moderate to severe hypertension","volume":"42","author":"Ohtsuka","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7792","key":"10.1016\/j.jpet.2026.104900_bib127","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-019-1924-6","article-title":"A distributional code for value in dopamine-based reinforcement learning","volume":"577","author":"Dabney","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jpet.2026.104900_bib128","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41593-024-01689-1","article-title":"A feature-specific prediction error model explains dopaminergic heterogeneity","volume":"27","author":"Lee","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpet.2026.104900_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fncom.2022.849323","article-title":"A mechanistic model of ADHD as resulting from dopamine phasic\/tonic imbalance during reinforcement learning","volume":"16","author":"V\u00e9ronneau-Veilleux","year":"2022","journal-title":"Front Comput Neurosci"},{"key":"10.1016\/j.jpet.2026.104900_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2024.103588","article-title":"Impaired flexible reward learning in ADHD patients is associated with blunted reinforcement sensitivity and neural signals in ventral striatum and parietal cortex","volume":"42","author":"Aster","year":"2024","journal-title":"Neuroimage Clin"},{"issue":"36","key":"10.1016\/j.jpet.2026.104900_bib131","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1523\/JNEUROSCI.3206-11.2011","article-title":"A Ca2+ threshold for induction of spike-timing-dependent depression in the mouse striatum","volume":"31","author":"Shindou","year":"2011","journal-title":"J Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526010992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526010992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:09:18Z","timestamp":1782720558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526010992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0022356526010992"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104900","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reinventing amlodipine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104900"}}